Today we're excited to announce $11M in funding and the antibody design platform we're building at Nabla Bio! bwnews.pr/3orAF4w

We’re proud to support Nabla Bio as they revolutionize protein engineering. Their use of protein language models to engineer better antibody therapies comes at a time when we desperately need them.

Congratulations Nabla Bio - welcome to the KV team! biospace.com/article/releas…

Congrats to Ali Hamed and the rest of the Crossbeam Venture Partners + CoVenture team on the new $70M fund! Definitely one to watch :) forbes.com/sites/rebeccas…

Here we go!!! We just announced our $6M Seed raise, which unlocks a new phase of growth for us in our journey to supercharge how scientific teams operate. You can read our press release to find out more, or check out Kyle LaHucik’s coverage in Endpoints News here: endpts.com/structure-beau…

Embeddable blocks for the open web!Very cool development from HASH and WordPress. Nice job Non Paribus, Joel Spolsky :)

I am really hoping Silicon Valley Bank pulls through this crisis. They have been a great partner to the tech ecosystem in 100 different ways. It’s actually a sad day for tech.

Always thoughtful, never shy thoughts on AI regulation from my friend Alex Iskold | 2048.vc

endpts.com/exclusive-two-…

Huge congratulations to my friend and instrumental former Recursionaut Ron Alfa on their series seed funding at NOETIK. Can’t wait to see what this team does! endpts.com/exclusive-two-…

Amen. Progress compounds - we overestimate what we can do in the short term and underestimate what we can do in the long run.

World models.

My favorite slide in new deck. Def still underselling. We took possession of an empty lab space Jan 2023.

Benchmarks are cool but there's nothing like In Vivo data on machine-learned biology to convince you this AI thing might be working... Exciting times NOETIK H/T @Ron_Alfa, Maxime Dhainaut, Yubin Xie, @Recursus, @HardimanJames

Today we announce the close of a $26M Series A financing, led by Radical Ventures with participation from all existing investors, and pharmaceutical collaborations with AstraZeneca, Bristol Myers Squibb, and Takeda. Thanks to Endpoints News for breaking our news. endpts.com/exclusive-astr…

The team that invented protein LLMs has $26M more to continue advancing state of the art, and partnerships with AstraZeneca, Bristol Myers Squibb, and Takeda worth $550M+ in upfront and milestone payments + royalties. Fifty Years led the pre-seed and supported every round since.

Excited to share Nabla Bio is partnering with 3 of the world’s largest pharma cos to use integrated AI and wet-lab tech to design antibodies against challenging disease targets. Thrilled to also add Radical Ventures who led our $26M Series A to the family! bit.ly/4dDk4lP

👀

Many people talk about "Foundation Models" for biology; NOETIK has already quietly built one Petabytes of proprietary data + novel model architectures = nuanced predictions of tumor response to arbitrary perturbation 🤯 The future comes at you fast dcvc.com/news-insights/…